Recent lecture of Irving Weissman focuses on possibilities of selective targeting of leukemic stem cell in human by manipulation of surface molecule – CD47.
Irving Weissman – Professor of Pathology and Developmental Biology at Stanford University and Director of the Stanford Comprehensive Cancer Center and Stanford Institute for Stem Cell Biology and Regenerative Medicine.
How to train the immune system to kill cancer stem cells?
Cancer stem cells – how mouse model can change the conceptComplexity of cancer stem cells
Validity of the cancer stem cell concept under discussion
Sean Morrison – Stem cell and cancer
Robert Weinberg – Cancer stem cells and malignant progression
Catriona Jamieson – The molecular evolution of leukemic stem cells
Irving Weissman – Stem Cells: Units in Regeneration, Cancer, and Natural Selection